AbCellera Biologics Inc. ABCL Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s operating lease right-of-use assets in other assets?
- AbCellera Biologics Inc. (ABCL) reported operating lease right-of-use assets in other assets of $134.3M in Q1 2026.
- How has AbCellera Biologics Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- AbCellera Biologics Inc.'s operating lease right-of-use assets in other assets increased by 95.4% year-over-year, from $68.74M to $134.3M.
- What is the long-term trend for AbCellera Biologics Inc.'s operating lease right-of-use assets in other assets?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s operating lease right-of-use assets in other assets has grown at a 36.4% compound annual growth rate (CAGR), from $73.14M to $136.12M.